Select Language:
The Chinese Academy of Engineering has acknowledged the open-source large language models developed by a Chinese AI startup and an AI chip created by an American tech company as among the top 10 engineering achievements worldwide.
The AI startup’s two language models—released between December of last year and January—pioneered a novel approach to exploring general artificial intelligence under limited resource conditions. They achieved this through innovative algorithms and engineering optimizations, positioning the company as one of the quickest-growing AI developers globally, as announced by a journal affiliated with the academy.
The American company’s graphics processing unit architecture, introduced last March, was designed to meet the complex computational requirements of AI inference. This architecture has significantly accelerated AI training, reduced inference latency to mere seconds, minimized computational thresholds for large models, and contributed to entering the trillion-parameter era of AI systems, according to the journal.
Since 2021, the institute has annually selected ten pioneering engineering achievements from major innovations completed over the previous five years that demonstrate practical effectiveness and have made a global impact. The list includes landmark projects, essential technical equipment, and groundbreaking technical innovations.
This year’s list also showcases significant tools for space and deep-sea exploration, such as NASA’s Perseverance Rover, the European Space Agency’s Euclid Space Telescope, and China’s full-ocean-depth manned submersible.
Among the major engineering projects recognized are China’s South-to-North Water Transfer Middle Route, aimed at optimizing the country’s water resource distribution, and the Taklimakan Desert “Edge-Locking” ecological barrier along its perimeter. Other breakthroughs include advanced carbon fiber composites, humanoid robots transitioning from laboratories to real-world applications, and antibody-drug conjugates used for targeted cancer treatments.